Does MACITENTAN Cause Pulmonary hypertension? 1,505 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,505 reports of Pulmonary hypertension have been filed in association with MACITENTAN (OPSYNVI). This represents 3.3% of all adverse event reports for MACITENTAN.
1,505
Reports of Pulmonary hypertension with MACITENTAN
3.3%
of all MACITENTAN reports
656
Deaths
1,147
Hospitalizations
How Dangerous Is Pulmonary hypertension From MACITENTAN?
Of the 1,505 reports, 656 (43.6%) resulted in death, 1,147 (76.2%) required hospitalization, and 70 (4.7%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 1,505 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
DASATINIB (249)
Which MACITENTAN Alternatives Have Lower Pulmonary hypertension Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE